CONTACT:
Douglas M. Tucker, PhD, MBA
Neurognostics, Inc.
Phone: 414-727-7950 x 110
Fax: 414-727-7952
E-mail: dtucker@neurognostics.com
Website: www.neurognostics.com
Milwaukee, WI, November 17, 2005 – Neurognostics, Inc., a Wisconsin company specializing in functional Magnetic Resonance Imaging (fMRI) products and services, announced today that it chose Specified Imaging, a Louisiana-based distributor of medical imaging products, as its first distributor of the MindState™ product line.
“We are really excited to sign on our first regional distributor,” said Len Seward, Neurognostics’ Vice President of Sales. “We believe this will provide us with a more focused and effective sales effort and give us a stronger physical presence in the market.”
Under the new distributorship, Neurognostics is able to expand the sale of its fMRI products and services – MindState™ fDAD™ and MindState™ fDPD™ – into the southeastern region of the United States. Neurognostics’ MindState™ product line enables clinicians to perform fMRI examinations easily and cost-effectively by avoiding the investment of time, money and the steep learning curve associated with starting up an fMRI practice.
“We welcome the opportunity to work with Neurognostics,” said Stacy McCoy, Specified Imaging’s CEO. “We feel that Neurognostics’ product line blends perfectly within the scope of our specialty. Their commitment to making fMRI technology available to the clinical community is also very appealing to us. We look forward to developing a strong, mutually beneficial relationship with Neurognostics.”
About Neurognostics, Inc.
Founded in 2003, Neurognostics develops clinical applications for fMRI. Neurognostics strives to standardize the way fMRI is performed in a clinical setting, whether it is used in preoperative neurosurgical procedures or to assess and manage patients with various neurological and neurodevelopmental disorders. fMRI is a powerful imaging technique that extends the capability of Magnetic Resonance (MR) imaging by providing information about the functioning of imaged tissue. The Company hopes that its fMRI products and services will enable healthcare professionals to achieve new ways to care for their patients.
